Market Closed -
Bombay S.E.
03:30:51 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
2.47
INR
|
-1.98%
|
|
-2.37%
|
+31.38%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
981.6
|
2,542
|
5,147
|
9,089
|
1,784
|
1,010
|
Enterprise Value (EV)
1 |
1,096
|
2,589
|
5,201
|
9,163
|
1,826
|
8,053
|
P/E ratio
|
203
x
|
164
x
|
148
x
|
709
x
|
207
x
|
163
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.32
x
|
2.41
x
|
5.14
x
|
8.52
x
|
2.36
x
|
1.45
x
|
EV / Revenue
|
1.48
x
|
2.46
x
|
5.19
x
|
8.59
x
|
2.42
x
|
11.6
x
|
EV / EBITDA
|
366
x
|
-476
x
|
607
x
|
-13.1
x
|
75.5
x
|
1,379
x
|
EV / FCF
|
-3.07
x
|
15.2
x
|
-400
x
|
-26.4
x
|
31.8
x
|
-96.4
x
|
FCF Yield
|
-32.6%
|
6.57%
|
-0.25%
|
-3.79%
|
3.14%
|
-1.04%
|
Price to Book
|
1.34
x
|
3.4
x
|
6.57
x
|
11.4
x
|
2.22
x
|
1.2
x
|
Nbr of stocks (in thousands)
|
6,19,333
|
6,19,333
|
6,19,333
|
6,19,333
|
6,19,333
|
6,19,333
|
Reference price
2 |
1.585
|
4.105
|
8.310
|
14.68
|
2.880
|
1.630
|
Announcement Date
|
01/10/18
|
05/09/19
|
06/11/20
|
23/12/21
|
10/09/22
|
21/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
741
|
1,054
|
1,002
|
1,066
|
755.1
|
695.5
|
EBITDA
1 |
2.997
|
-5.437
|
8.569
|
-701.8
|
24.18
|
5.842
|
EBIT
1 |
1.231
|
-8.532
|
5.552
|
-704.1
|
22.1
|
1.909
|
Operating Margin
|
0.17%
|
-0.81%
|
0.55%
|
-66.04%
|
2.93%
|
0.27%
|
Earnings before Tax (EBT)
1 |
7.227
|
22.48
|
48.94
|
19.22
|
21.76
|
15.3
|
Net income
1 |
4.829
|
15.65
|
34.7
|
12.83
|
8.62
|
6.667
|
Net margin
|
0.65%
|
1.48%
|
3.46%
|
1.2%
|
1.14%
|
0.96%
|
EPS
2 |
0.007796
|
0.0250
|
0.0560
|
0.0207
|
0.0139
|
0.009999
|
Free Cash Flow
1 |
-357.4
|
170.2
|
-13.02
|
-347.1
|
57.42
|
-83.56
|
FCF margin
|
-48.23%
|
16.15%
|
-1.3%
|
-32.55%
|
7.6%
|
-12.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
237.44%
|
-
|
FCF Conversion (Net income)
|
-
|
1,087.64%
|
-
|
-
|
666.07%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/10/18
|
05/09/19
|
06/11/20
|
23/12/21
|
10/09/22
|
21/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
114
|
46.8
|
54.5
|
74
|
42.5
|
7,044
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
38.11
x
|
-8.604
x
|
6.365
x
|
-0.1054
x
|
1.757
x
|
1,206
x
|
Free Cash Flow
1 |
-357
|
170
|
-13
|
-347
|
57.4
|
-83.6
|
ROE (net income / shareholders' equity)
|
0.69%
|
2.11%
|
4.53%
|
1.62%
|
1.08%
|
0.78%
|
ROA (Net income/ Total Assets)
|
0.04%
|
-0.25%
|
0.15%
|
-24%
|
1.03%
|
0.02%
|
Assets
1 |
13,451
|
-6,345
|
22,443
|
-53.53
|
840.7
|
27,324
|
Book Value Per Share
2 |
1.180
|
1.210
|
1.260
|
1.290
|
1.300
|
1.360
|
Cash Flow per Share
2 |
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0200
|
0.0100
|
Capex
1 |
65.9
|
0.39
|
6.22
|
1.9
|
24.9
|
24.5
|
Capex / Sales
|
8.89%
|
0.04%
|
0.62%
|
0.18%
|
3.29%
|
3.52%
|
Announcement Date
|
01/10/18
|
05/09/19
|
06/11/20
|
23/12/21
|
10/09/22
|
21/09/23
|
|
1st Jan change
|
Capi.
|
---|
| +31.38% | 20.93M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|